Table 2.
Comparison of weight, BMI, sex hormones, IR and depression scores before and after 12 weeks between both groups mean ± standard deviation (SD).
| Variables | Experimental group (n = 30) |
95%Cl (lower, upper) | PPaired t-test –value | Control group (n = 30) |
95%Cl (lower, upper) | PPaired t-test -value | 95%Cl (lower, upper) | PIndep.t-test value | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Before | After | Before | After | |||||||
| Weight (kg) | 97.42 ± 6.18 | 79.22 ± 6.07 | (17.50, 18.92) | <0.001 ∗ | 94.87 ± 5.20 | 85.96 ± 15.52 | (3.19, 14.63) | <0.05 ∗ | (-12.79, -0.70) | 0.001∗∗ |
| BMI (kg/m2) | 37.88 ± 1.93 | 33.02 ± 1.92 | (4.66,5.06) | <0.001 ∗ | 37.47 ± 1.39 | 34.62 ± 1.56 | (2.56,3.15) | <0.05 ∗ | (-2.50, -0.70) | 0.001∗∗ |
| Estradiol hormone (Pg/ml) | 26.02 ± 3.66 | 20.71 ± 3.02 | (5.01,5.61) | <0.001 ∗ | 26.22 ± 3.22 | 23.48 ± 2.94 | (2.53–2.94) | <0.05 ∗ | (-4.31, -1.23) | 0.001∗∗ |
| Total testosterone hormone (ng/ml) | 0.44 ± 0.10 | 0.27 ± 0.07 | (0.15,0.20) | <0.001 ∗ | 0.40 ± 0.11 | 0.37 ± 0.11 | (0.02,0.03) | <0.05 ∗ | (-0.15, -0.06) | 0.001∗∗ |
| Free testosterone hormone (pg/ml) | 1.44 ± 0.57 | 0.77 ± 0.3 | (0.55,0.79) | <0.001 ∗ | 1.54 ± 0.66 | 1.40 ± 0.60 | (0.11,0.16) | <0.05 ∗ | (-0.88, -0.39) | 0.001∗∗ |
| SHBG hormone (nmol/ml) | 40.25 ± 5.06 | 49.36 ± 6.28 | (-9.63, -8.59) | <0.001 ∗ | 39.39 ± 5.00 | 43.32 ± 5.59 | (-4.32, -3.55) | <0.05 ∗ | (2.96,9.11) | 0.001∗∗ |
| HOMA-IR index | 2.65 ± 0.59 | 2.08 ± 0.47 | (0.52,0.63) | <0.001 ∗ | 2.63 ± 0.45 | 2.33 ± 0.41 | (0.27,0.32) | <0.05 ∗ | (-0.48, -0.03) | 0.001∗∗ |
| Depression scores | 54.90 ± 2.64 | 35.10 ± 3.00 | (18.67,20.93) | <0.001 ∗ | 54.33 ± 2.45 | 40.07 ± 1.95 | (13.31,15.22) | <0.05 ∗ | (-6.27, -3.66) | 0.001∗∗ |
BMI: Body mass index, SHBG: Sex Hormone Binding Globulin. HOMA-IR index: Homeostatic Model Assessment for Insulin Resistance.
∗: Statistically significant at P ≤ 0.05 according to Paired Sample t-test.
∗∗: Statistically significant at P ≤ 0.05 according to Independent Sample t-test.